PFS Partners, LLC

Position in OGN — Organon & Co.

CIK 2002654 MINE HILL, NJ

Position in OGN

as of Jun 30, 2026 · filed Jul 20, 2026 Compact

Position Value

$4,265

+$2,343 QoQ

Shares Held

315

-1.9% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#374

of 626 holders

Holding Since

Dec 2021

19 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

PFS Partners, LLC holds $1,820,727 across 11 Drug Manufacturers - General names. OGN ranks #10 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	4,033	$518,240
2	ABBV	AbbVie Inc.	1,870	$470,566
3	LLY	ELI LILLY & Co	321	$385,017
4	JNJ	Johnson & Johnson	1,319	$334,986
5	PFE	Pfizer Inc	2,478	$59,670
6	AMGN	Amgen Inc	44	$15,933
7	GILD	Gilead Sciences, Inc.	95	$12,002
8	AZN	Astrazeneca PLC	55	$10,429

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,265	315	-1.9%	Shares	Sole	2026-07-20
2026-03-31	$1,922	321	-1.5%	Shares	Sole	2026-04-09
2025-12-31	$2,337	326	+0.3%	Shares	Sole	2026-01-16
2025-09-30	$3,471	325	+0.3%	Shares	Sole	2025-10-16
2025-06-30	$3,136	324	+0.3%	Shares	Sole	2025-07-16
2025-03-31	$4,809	323	+1.6%	Shares	Sole	2025-04-14
2024-12-31	$4,744	318	+0.3%	Shares	Sole	2025-01-27
2024-09-30	$6,064	317	+1.3%	Shares	Sole	2024-11-01
2024-06-30	$6,479	313	+1.6%	Shares	Sole	2024-07-25
2024-03-31	$5,790	308	+1.0%	Shares	Sole	2024-04-15
2023-12-31	$4,398	305	+2.3%	Shares	Sole	2024-01-29
2023-09-30	$5,173	298	+1.4%	Shares	Sole	2023-12-01
2023-06-30	$6,118	294	+1.4%	Shares	Sole	2023-12-01
2023-03-31	$6,820	290	+1.4%	Shares	Sole	2023-12-01
2022-12-31	$7,987	286	+5.1%	Shares	Sole	2023-12-01
2022-09-30	$6,364	272	+0.7%	Shares	Sole	2023-12-01
2022-06-30	$9,112	270	+0.7%	Shares	Sole	2023-12-01
2022-03-31	$9,361	268	-1.1%	Shares	Sole	2023-12-01
2021-12-31	$8,251	271	—	Shares	Sole	2023-12-01
No filing history on record for this holder in this stock.